Table 6.
TRIAL I. Monthly changes in values of individual symptoms determined according to Greene’s Menopausal Score (GMS) for APMM sequence treatment (n=55) in early-postmenopausal women recorded between Admission (A), and three monthly sampling points (Month Model)a with one month Placebo (P) followed by two months Maca-GO (M) contrast (Treatment Model)1 according to the sequence applied in Trial I
| Individual Menopausal Symptoms’ Scores according to Greene | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Symptom | Admission A | After Month 1 (P) | After Month 2 (M) | After Month 3 (M) | ±SEDb | Pc | Placebo | Maca | ±SEDb | Pc |
| Abnormally-fast heart rate | 0.66 | 0.45 | 0.35 | 0.28 | 0.149 | 0.094 | 0.455 | 0.315 | 0.118 | 0.240 |
| Nervousness | 1.51 | 1.68 | 1.00 | 0.76 | 0.200 | <0.001 | 1.682 | 0.879 | 0.169 | <0.001 |
| Difficulty falling asleep | 1.15 | 1.12 | 0.77 | 0.52 | 0.212 | 0.009 | 1.121 | 0.646 | 0.169 | 0.006 |
| Excessive alertness | 1.33 | 1.33 | 1.00 | 0.55 | 0.175 | <0.001 | 1.333 | 0.776 | 0.147 | <0.001 |
| Sudden feeling of anxiety | 0.82 | 0.70 | 0.45 | 0.45 | 0.193 | 0.145 | 0.697 | 0.450 | 0.169 | 0.147 |
| Difficulty concentrating | 0.97 | 1.09 | 0.94 | 0.41 | 0.182 | 0.002 | 1.091 | 0.675 | 0.153 | 0.008 |
| Feeling of tiredness/lack of energy | 1.39 | 1.54 | 1.32 | 0.72 | 0.205 | <0.001 | 1.545 | 1.023 | 0.173 | 0.003 |
| Lack of interest | 0.36 | 0.33 | 0.26 | 0.21 | 0.129 | 0.612 | 0.333 | 0.233 | 0.111 | 0.037 |
| Unhappy/depressed | 1.00 | 0.94 | 0.74 | 0.45 | 0.201 | 0.030 | 0.939 | 0.595 | 0.174 | 0.050 |
| Excessive crying | 0.45 | 0.27 | 0.23 | 0.24 | 0.129 | 0.263 | 0.273 | 0.234 | 0.109 | 0.721 |
| Irritability | 1.27 | 1.15 | 0.84 | 0.65 | 0.189 | 0.005 | 1.152 | 0.747 | 0.165 | 0.016 |
| Loss of consciousness | 0.61 | 0.88 | 0.45 | 0.41 | 0.170 | 0.030 | 0.879 | 0.433 | 0.147 | 0.003 |
| Nervous tension | 0.72 | 0.59 | 0.52 | 0.41 | 0.156 | 0.238 | 0.591 | 0.465 | 0.133 | 0.345 |
| Numbness/“pins & needles” | 0.67 | 0.61 | 0.45 | 0.31 | 0.183 | 0.207 | 0.606 | 0.381 | 0.153 | 0.144 |
| Headaches | 0.97 | 0.85 | 0.58 | 0.34 | 0.206 | 0.014 | 0.848 | 0.463 | 0.167 | 0.023 |
| Muscle and joint aches and pains | 1.24 | 1.18 | 0.97 | 0.62 | 0.224 | 0.027 | 1.182 | 0.794 | 0.193 | 0.047 |
| Loss of feeling in feet & hands | 0.45 | 0.36 | 0.19 | 0.24 | 0.148 | 0.284 | 0.364 | 0.217 | 0.123 | 0.239 |
| Difficulty breathing | 0.27 | 0.12 | 0.16 | 0.10 | 0.097 | 0.303 | 0.121 | 0.132 | 0.073 | 0.879 |
| Hot flushes | 1.73 | 1.73 | 1.10 | 0.52 | 0.257 | <0.001 | 1.727 | 0.807 | 0.210 | <0.001 |
| Excessive night sweating | 1.45 | 1.39 | 1.06 | 0.48 | 0.253 | <0.001 | 1.394 | 0.774 | 0.203 | 0.003 |
| Loss of interest in sex life | 1.06 | 1.12 | 0.84 | 0.60 | 0.200 | 0.036 | 1.121 | 0.712 | 0.173 | 0.020 |
| TOTAL GMS | 20.09 | 19.45 | 13.36 | 8.15 | 1.869 | <0.001 | 19.45 | 10.76 | 0.16 | <0.001 |
For explanation see Table 1;
SED, Standard error of differences;
P, Probabilities of significance. ns, not significant at P>0.05; P<0.05, significance at 5% probability level; P<0.01, significance at 1% probability level; P<0.001, significance at 0.1% probability level.